Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Zelluna ASA (Norway)
Homepage:
zelluna.com
Alternate names:
Zelluna,
Zelluna A,
Zelluna ASA,
Zelluna Immunotherapy AS
ROR:
051906v36
OpenAlex ID:
I4405267916
Works
8
Awards
8
Efficient in vivo generation of CAR T cells using a retargeted fourth-generation lentiviral vector
2025
·
Tiziana Coradin
, Amy L. Keating
, et al.
·
Molecular Therapy
·
56
A call to adapt the regulation of HLA testing for T cell receptor-based therapeutics
2023
·
Miriam Meyer
, Andrea Mahr
, et al.
·
Nature Reviews Drug Discovery
·
6
Preclinical assessment of MAGE-A4-specific TCR-NK cells against solid tumors
2025
·
Margherita Boieri
, Justyna Kmiecik
, et al.
·
Immunotherapy Advances
·
1
Abstract 1329: Development of the first optimised “off the shelf” MAGE-A4 targeting TCR-NK cells for advancement into the clinic for the treatment of solid tumors
2024
·
Sarah Vollmers
, Artur Cieslar-Pobuda
, et al.
·
Cancer Research
·
1
561 Clinical and translational evaluation of ZI-MA4-1, a first-in-class MAGE-A4-targeting TCR-NK cell therapy in advanced solid tumours: design of the ZIMA-101 study
2026
·
Fiona Thistlethwaite
, Andrew JS Furness
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
373 Development of the first optimised ‘off the shelf’ MAGE-A4 targeting TCR-NK cells for advancement into the clinic for the treatment of solid tumors
2024
·
Zara Hannoun
, Anja R Oldenburg
, et al.
·
Journal for ImmunoTherapy of Cancer
349 A novel ‘off the shelf’ TCR-NK cell therapy platform for the treatment of solid tumours: development of optimised MAGE-A4 targeting TCR-NK cells for advancement into the clinic
2023
·
Ines Cardoso
, Sylvie Pollmann
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Show more works
View as search
Works count:
8
Citation count:
110
Year
Topic
Type